Skip to main content

World Measles cases nearly quadrupled in first quarter 2019: WHO

The number of measles cases worldwide nearly quadrupled in the first quarter of 2019 to 112,163 against the same period last year, the World Health Organization (WHO) said on Monday, citing provisional data.

Higher rates of the preventable but contagious disease – which can kill a child or leave it blind, deaf or brain-damaged – have been recorded in all regions, the United Nations agency said in a statement, appealing for better vaccination coverage.

Fresh outbreaks have hit the Democratic Republic of Congo, Ethiopia, Georgia, Kazakhstan, Kyrgyzstan, Madagascar, Myanmar, the Philippines, Sudan, Thailand and Ukraine, “causing many deaths – mostly among young children”, the WHO said.

Story continues below advertisement

It gave no figures for fatalities but noted it estimates that only one in 10 cases is reported globally.

“Over recent months, spikes in case numbers have also occurred in countries with high overall vaccination coverage, including the United States of America as well as Israel, Thailand, and Tunisia, as the disease has spread fast among clusters of unvaccinated people,” the WHO statement said.

U.S. federal health officials said on Monday the number of confirmed cases of measles in the United States this year jumped by nearly 20 per cent in the week ended April 11 – the country’s second-worst outbreak in nearly two decades.

A growing and vocal fringe of parents in the United States oppose measles vaccines in the belief, contrary to scientific evidence, that ingredients in the vaccines can cause autism or other disorders.

Increasing vaccination coverage maximizes a population’s protection, the WHO said. Global coverage with the first dose has “stalled” at 85 per cent, against 95 per cent needed to prevent outbreaks, while 25 countries still do not include a second dose in their national programmes, it said.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter